BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32888783)

  • 21. C3a and Its Receptor C3aR Are Detectable in Normal Human Epidermal Keratinocytes and Are Differentially Regulated via TLR3 and LL37.
    Mommert S; Doenni L; Szudybill P; Zoeller C; Beyer FH; Werfel T
    J Innate Immun; 2021; 13(3):164-178. PubMed ID: 33445177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oligodeoxynucleotides inhibit Toll-like receptor 3 mediated cytotoxicity and CXCL8 release in keratinocytes.
    Grimstad O; Pukstad B; Stenvik J; Espevik T
    Exp Dermatol; 2012 Jan; 21(1):7-12. PubMed ID: 22082188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TLR3 activation efficiency by high or low molecular mass poly I:C.
    Zhou Y; Guo M; Wang X; Li J; Wang Y; Ye L; Dai M; Zhou L; Persidsky Y; Ho W
    Innate Immun; 2013; 19(2):184-92. PubMed ID: 23035017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polyinosinic-polycytidylic acid induces innate immune responses via Toll-like receptor 3 in human ovarian granulosa cells.
    Yan K; Liang J; Zhang X; Deng L; Feng D; Ling B
    Immunol Cell Biol; 2019 Sep; 97(8):753-765. PubMed ID: 31111539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surface Toll-like receptor 3 expression in metastatic intestinal epithelial cells induces inflammatory cytokine production and promotes invasiveness.
    Bugge M; Bergstrom B; Eide OK; Solli H; Kjønstad IF; Stenvik J; Espevik T; Nilsen NJ
    J Biol Chem; 2017 Sep; 292(37):15408-15425. PubMed ID: 28717003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthetic double-stranded RNA induces multiple genes related to inflammation through Toll-like receptor 3 depending on NF-kappaB and/or IRF-3 in airway epithelial cells.
    Matsukura S; Kokubu F; Kurokawa M; Kawaguchi M; Ieki K; Kuga H; Odaka M; Suzuki S; Watanabe S; Takeuchi H; Kasama T; Adachi M
    Clin Exp Allergy; 2006 Aug; 36(8):1049-62. PubMed ID: 16911361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The zinc-finger protein ZFYVE1 modulates TLR3-mediated signaling by facilitating TLR3 ligand binding.
    Zhong X; Feng L; Xu WH; Wu X; Ding YD; Zhou Y; Lei CQ; Shu HB
    Cell Mol Immunol; 2020 Jul; 17(7):741-752. PubMed ID: 31388100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-1 receptor antagonist mediates toll-like receptor 3-induced inhibition of trophoblast adhesion to endometrial cells in vitro.
    Montazeri M; Sanchez-Lopez JA; Caballero I; Maslehat Lay N; Elliott S; Fazeli A
    Hum Reprod; 2016 Sep; 31(9):2098-107. PubMed ID: 27412245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Molecular Chaperone GRP78 Contributes to Toll-like Receptor 3-mediated Innate Immune Response to Hepatitis C Virus in Hepatocytes.
    Wei D; Li NL; Zeng Y; Liu B; Kumthip K; Wang TT; Huo D; Ingels JF; Lu L; Shang J; Li K
    J Biol Chem; 2016 Jun; 291(23):12294-309. PubMed ID: 27129228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TLR3-mediated IFN-β gene induction is negatively regulated by the TLR adaptor MyD88 adaptor-like.
    Siednienko J; Halle A; Nagpal K; Golenbock DT; Miggin SM
    Eur J Immunol; 2010 Nov; 40(11):3150-60. PubMed ID: 20957750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of toll-like receptors 2, 3 or 5 induces matrix metalloproteinase-1 and -9 expression with the involvement of MAPKs and NF-kappaB in human epidermal keratinocytes.
    Lee Y; Kim H; Kim S; Kim KH; Chung JH
    Exp Dermatol; 2010 Aug; 19(8):e44-9. PubMed ID: 19758322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidermal keratinocytes sense dsRNA via the NLRP3 inflammasome, mediating interleukin (IL)-1β and IL-18 release.
    Dai X; Tohyama M; Murakami M; Sayama K
    Exp Dermatol; 2017 Oct; 26(10):904-911. PubMed ID: 28266737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Keratinocytes synthesize and activate cortisol.
    Cirillo N; Prime SS
    J Cell Biochem; 2011 Jun; 112(6):1499-505. PubMed ID: 21344493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toll-like receptors 2 and 3 enhance melanogenesis and melanosome transport in human melanocytes.
    Koike S; Yamasaki K; Yamauchi T; Inoue M; Shimada-Ohmori R; Tsuchiyama K; Aiba S
    Pigment Cell Melanoma Res; 2018 Sep; 31(5):570-584. PubMed ID: 29603875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toll-like receptor 3 mediates expression of clusterin/apolipoprotein J in vascular smooth muscle cells stimulated with RNA released from necrotic cells.
    Baiersdörfer M; Schwarz M; Seehafer K; Lehmann C; Heit A; Wagner H; Kirschning CJ; Koch-Brandt C
    Exp Cell Res; 2010 Dec; 316(20):3489-500. PubMed ID: 20692254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploiting poly(I:C) to induce cancer cell apoptosis.
    Bianchi F; Pretto S; Tagliabue E; Balsari A; Sfondrini L
    Cancer Biol Ther; 2017 Oct; 18(10):747-756. PubMed ID: 28881163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes.
    Yamasaki K; Kanada K; Macleod DT; Borkowski AW; Morizane S; Nakatsuji T; Cogen AL; Gallo RL
    J Invest Dermatol; 2011 Mar; 131(3):688-97. PubMed ID: 21107351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PHF11 expression and cellular distribution is regulated by the Toll-Like Receptor 3 Ligand Polyinosinic:Polycytidylic Acid in HaCaT keratinocytes.
    Muscat P; Mercado K; Payne K; Chahal H; Jones G
    BMC Immunol; 2015 Nov; 16():69. PubMed ID: 26573531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toll-like receptor 3 (TLR3) signaling requires TLR4 Interactor with leucine-rich REPeats (TRIL).
    Carpenter S; Wochal P; Dunne A; O'Neill LAJ
    J Biol Chem; 2011 Nov; 286(44):38795-38804. PubMed ID: 21911501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toll-like receptor 3 signaling contributes to the expression of a neutrophil chemoattractant, CXCL1 in human mesangial cells.
    Imaizumi T; Aizawa T; Segawa C; Shimada M; Tsuruga K; Kawaguchi S; Matsumiya T; Yoshida H; Joh K; Tanaka H
    Clin Exp Nephrol; 2015 Oct; 19(5):761-70. PubMed ID: 25471749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.